Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or co-insurance benefit designs.

🔗 Read more: https://www.cnbc.com/2026/02/24/novo-nordisk-to-slash-wegovy-ozempic-us-list-prices-by-up-to-50percent.html

#News #Health #Medicine #Business